Bright Minds Biosciences Inc.
General ticker "DRUG" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $208.8M (TTM average)
Bright Minds Biosciences Inc. follows the US Stock Market performance with the rate: 48.5%.
Estimated limits based on current volatility of 3.3%: low 70.87$, high 75.70$
Factors to consider:
- Total employees count: 2 as of 2022
- Current price 3279.4% above estimated high
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [0.77$, 2.11$]
- 2025-09-30 to 2026-09-30 estimated range: [0.80$, 2.15$]
Financial Metrics affecting the DRUG estimates:
- Positive: with PPE of -2.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -26.04 <= 0.33
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Shareholder equity ratio, % of 90.69 > 63.39
- Positive: Inventory ratio change, % of 0 <= 0
Short-term DRUG quotes
Long-term DRUG plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 |
|---|---|---|
| Operating Revenue | CA$0.00MM | CA$0.00MM |
| Operating Expenses | CA$7.20MM | CA$2.62MM |
| Operating Income | CA$-7.20MM | CA$-2.62MM |
| Non-Operating Income | CA$-0.17MM | CA$-0.19MM |
| R&D Expense | CA$5.00MM | CA$1.18MM |
| Income(Loss) | CA$-7.37MM | CA$-2.80MM |
| Profit(Loss)* | CA$-7.37MM | CA$-2.80MM |
| Stockholders Equity | CA$6.60MM | CA$5.54MM |
| Assets | CA$6.88MM | CA$6.10MM |
| Operating Cash Flow | CA$-7.02MM | CA$-1.85MM |
| Capital expenditure | CA$0.00MM | CA$0.00MM |
| Financing Cash Flow | CA$2.19MM | CA$0.81MM |
| Earnings Per Share** | CA$-1.98 | CA$-0.65 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.